| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1993PNAS...9010198H |
| P356 | DOI | 10.1073/PNAS.90.21.10198 |
| P932 | PMC publication ID | 47741 |
| P698 | PubMed publication ID | 8234277 |
| P5875 | ResearchGate publication ID | 14965567 |
| P50 | author | R. John Collier | Q2123854 |
| P2093 | author name string | D Acosta | |
| P C Hanna | |||
| P2860 | cites work | Contribution of individual toxin components to virulence of Bacillus anthracis | Q24652917 |
| Anthrax vaccines: past, present and future | Q28242203 | ||
| Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
| Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells | Q28609196 | ||
| Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia | Q34173960 | ||
| Shock and tissue injury induced by recombinant human cachectin | Q34189904 | ||
| The staphylococcal enterotoxins and their relatives. | Q34209384 | ||
| Interaction of Staphylococcus aureus toxin "superantigens" with human T cells | Q34319909 | ||
| T-cell-dependent shock induced by a bacterial superantigen | Q35453275 | ||
| Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells | Q36987540 | ||
| Differences in susceptibility of inbred mice to Bacillus anthracis | Q37028114 | ||
| Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells | Q37374866 | ||
| Damage to cell membranes by pore-forming bacterial cytolysins. | Q38186796 | ||
| Anthrax in wildlife in the Luangwa Valley, Zambia | Q38704936 | ||
| Biology of interleukin 1. | Q39629154 | ||
| Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process | Q44386336 | ||
| Interleukin-1 receptor antagonist reduces mortality from endotoxin shock | Q59092106 | ||
| Construction and characterization of a protective antigen-deficient Bacillus anthracis strain | Q68364070 | ||
| Elimination of macrophages with silica and asbestos | Q72411916 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 10198-10201 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | On the role of macrophages in anthrax | |
| P478 | volume | 90 |
| Q34712623 | 2001: a year of major advances in anthrax toxin research |
| Q43559735 | A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo |
| Q35143862 | A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen |
| Q33275326 | A high-throughput screening approach to anthrax lethal factor inhibition |
| Q36846447 | A mathematical simulation of the inflammatory response to anthrax infection |
| Q37587597 | Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation |
| Q33371102 | Activity of the Bacillus anthracis 20 kDa protective antigen component |
| Q47883255 | Administration of silica sensitizes lipopolysaccharide responsiveness of murine macrophages but inhibits T and B cell priming by inhibition of antigen presenting function |
| Q39825337 | Analysis of epithelial cell stress response during infection by Shigella flexneri |
| Q58919748 | Anthrax Lethal Toxin Inhibits the Production of Proinflammatory Cytokines |
| Q26796601 | Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination |
| Q38912774 | Anthrax and other microbial threats |
| Q40375668 | Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. |
| Q24650441 | Anthrax in America 2001-2003 |
| Q36642550 | Anthrax lethal factor activates K(+) channels to induce IL-1β secretion in macrophages |
| Q28610275 | Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha |
| Q38279238 | Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies. |
| Q35073710 | Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival |
| Q40582456 | Anthrax lethal toxin induces human endothelial cell apoptosis |
| Q40580486 | Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18. |
| Q24816298 | Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response |
| Q33764677 | Anthrax toxin as a molecular tool for stimulation of cytotoxic T lymphocytes: disulfide-linked epitopes, multiple injections, and role of CD4(+) cells |
| Q40319858 | Anthrax toxin protective antigen: inhibition of channel function by chloroquine and related compounds and study of binding kinetics using the current noise analysis |
| Q34170413 | Anthrax toxin receptor proteins |
| Q33750314 | Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin |
| Q37242580 | Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo |
| Q34999660 | Anthrax toxin: a tripartite lethal combination |
| Q34446432 | Anthrax: a motor protein determines anthrax susceptibility |
| Q36399765 | Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists |
| Q34227176 | Anti-TNF-alpha therapies: the next generation |
| Q34714854 | Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host |
| Q37093742 | Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents. |
| Q37075422 | Association of Bacillus anthracis capsule with lethal toxin during experimental infection |
| Q30651835 | Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax |
| Q34751958 | Bacillus anthracis as an agent of bioterrorism: a review emphasizing surgical treatment |
| Q35679008 | Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice |
| Q42153388 | Bacillus anthracis spores and lethal toxin induce IL-1beta via functionally distinct signaling pathways |
| Q28389931 | Bacillus anthracis' lethal toxin induces broad transcriptional responses in human peripheral monocytes |
| Q36895609 | Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. |
| Q33675805 | Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion |
| Q35134735 | Bacillus spores for vaccine delivery. |
| Q35966527 | Bacterial infection as assessed by in vivo gene expression |
| Q33838168 | Bacterial toxins with intracellular protease activity. |
| Q39011436 | Bidirectional effect of Wnt signaling antagonist DKK1 on the modulation of anthrax toxin uptake. |
| Q24562788 | Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins |
| Q33246181 | Cationic polyamines inhibit anthrax lethal factor protease |
| Q37195729 | Cell death in the host response to infection |
| Q27010363 | Cellular and physiological effects of anthrax exotoxin and its relevance to disease |
| Q37441837 | Cellular and systemic effects of anthrax lethal toxin and edema toxin |
| Q39163100 | Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis |
| Q35781403 | Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability |
| Q95788288 | Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients |
| Q42363492 | Constitutive MEK1 Activation Rescues Anthrax Lethal Toxin-Induced Vascular Effects In Vivo |
| Q27636113 | Crystal structure of the anthrax lethal factor |
| Q33609374 | Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. |
| Q34334441 | Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4. |
| Q37582916 | Cytokine response to infection with Bacillus anthracis spores |
| Q35834195 | Death at Sverdlovsk: what have we learned? |
| Q33378594 | Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy |
| Q40702131 | Delayed treatment with doxycycline has limited effect on anthrax infection in BLK57/B6 mice |
| Q34805048 | Designed azolopyridinium salts block protective antigen pores in vitro and protect cells from anthrax toxin |
| Q34744925 | Development of an improved vaccine for anthrax |
| Q30638627 | Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors |
| Q57214133 | Effect of Anthrax Toxin's Lethal Factor on Ion Channels Formed by the Protective Antigen |
| Q44130997 | Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells |
| Q34117219 | Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization |
| Q33868811 | Efficient synthetic inhibitors of anthrax lethal factor |
| Q33883570 | Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin |
| Q30449524 | Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages |
| Q37405396 | Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen |
| Q34544688 | Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells |
| Q33716119 | GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis |
| Q34100366 | Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin |
| Q44785556 | Histopathological effects of anthrax lethal factor on rat liver |
| Q24806902 | Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed |
| Q44389292 | Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin |
| Q33576071 | In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model |
| Q42635842 | Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations |
| Q37355950 | Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination |
| Q43759738 | Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor |
| Q28383094 | Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy |
| Q33754138 | Lethal factor active-site mutations affect catalytic activity in vitro. |
| Q40838321 | Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages |
| Q52536287 | Lethal toxin actions and their consequences. |
| Q40726662 | Lethal toxin of Bacillus anthracis causes apoptosis of macrophages |
| Q44364250 | Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats |
| Q54126677 | Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11. |
| Q40563963 | Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores |
| Q33713102 | Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis |
| Q37365701 | Mathematical and computational approaches can complement experimental studies of host-pathogen interactions |
| Q40108866 | Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-induced macrophage cell death. |
| Q35661015 | Modeling the host response to inhalation anthrax |
| Q41136315 | Molecular mechanisms of action of bacterial exotoxins. |
| Q33792559 | Molecular pathogenesis of Bacillus anthracis infection |
| Q36445590 | Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity |
| Q35783849 | Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains |
| Q28586508 | Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin |
| Q36842720 | New insights into the pathogenesis and treatment of anthrax toxin-induced shock |
| Q34000910 | Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells |
| Q30696618 | Passive transfer of protection against Bacillus anthracis infection in a murine model |
| Q28395786 | Pathology and pathogenesis of bioterrorism-related inhalational anthrax |
| Q44550683 | Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). |
| Q37370249 | Perspectives series: host/pathogen interactions. Apoptosis in bacterial pathogenesis |
| Q34194628 | Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge |
| Q37622662 | Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage |
| Q34001220 | Proteasome activity is required for anthrax lethal toxin to kill macrophages |
| Q35400677 | Protective immunity induced by Bacillus anthracis toxin-deficient strains. |
| Q53599723 | Proteomics study of anthrax lethal toxin-treated murine macrophages. |
| Q34191394 | Provider and health care system response to a bioterrorist attack. |
| Q34545284 | Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages |
| Q59760760 | Pyroptosis: A Caspase-1-Dependent Programmed Cell Death and a Barrier to Infection |
| Q28189054 | Quantitative pathology of inhalational anthrax I: quantitative microscopic findings |
| Q34517609 | Quickening the pace of anthrax research: three advances point towards possible therapies |
| Q24532114 | Receptor-specific requirements for anthrax toxin delivery into cells |
| Q36313906 | Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen. |
| Q44551578 | Regulation of the G2/M transition in oocytes of xenopus tropicalis |
| Q37405414 | Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin |
| Q41919948 | Role of furin in delivery of a CTL epitope of an anthrax toxin-fusion protein |
| Q36437476 | Role of macrophage oxidative burst in the action of anthrax lethal toxin. |
| Q44253547 | Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha |
| Q33999912 | Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells |
| Q24532224 | Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor |
| Q33587520 | Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1 |
| Q34825848 | The alveolar macrophage: the Trojan horse of Bacillus anthracis |
| Q42139297 | The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors |
| Q39857969 | The host response to anthrax lethal toxin: unexpected observations |
| Q29616025 | The inflammasome NLRs in immunity, inflammation, and associated diseases |
| Q27024163 | The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock |
| Q33548737 | The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells |
| Q33291819 | The seminal literature of anthrax research |
| Q37060218 | The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax |
| Q27642935 | The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor |
| Q37231557 | Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor |
| Q41912400 | Toxin Transport by A-B Type of Toxins in Eukaryotic Target Cells and Its Inhibition by Positively Charged Heterocyclic Molecules |
| Q36350534 | Toxin-induced resistance in Bacillus anthracis lethal toxin-treated macrophages. |
| Q34398303 | Toxins of Bacillus anthracis |
| Q30440528 | Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis |
| Q34545303 | Tropheryma whipplei, the Whipple's disease bacillus, induces macrophage apoptosis through the extrinsic pathway. |
| Q41943950 | Ultrastructural features of lymphocyte suppression induced by anthrax lethal toxin and treated with chloroquine. |
| Q33670648 | Understanding Bacillus anthracis pathogenesis |
| Q24623274 | Unifying themes in microbial associations with animal and plant hosts described using the gene ontology |
Search more.